21 – 30 of 649
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
SERPINH1 variants and thrombotic risk among middle-aged and older adults : a population-based cohort study
(
- Contribution to journal › Letter
-
Mark
Haemophilia A - In pursuit of optimised outcomes via personalised treatment
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Health-related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study)
(
- Contribution to journal › Article
-
Mark
Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8) : a prospective, multicentre, open-label, randomised, phase 3a trial
(
- Contribution to journal › Article
- 2023
-
Mark
Matching-adjusted indirect comparison of bleeding outcomes in severe haemophilia A : Comparing valoctocogene roxaparvovec gene therapy, emicizumab prophylaxis, and FVIII replacement prophylaxis
(
- Contribution to journal › Article
-
Mark
Association of Circulating Long Noncoding 7S RNA with Deep Vein Thrombosis
(
- Contribution to journal › Article
-
Mark
Lung function, respiratory symptoms and incident venous thromboembolism during a 44-year follow-up
(
- Contribution to journal › Article
-
Mark
Entrustable professional activities (EPAs) for undergraduate medical education – development and exploration of social validity
(
- Contribution to journal › Article
-
Mark
Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia : A review of the literature
(
- Contribution to journal › Scientific review
-
Mark
Clinical, economic, and health-related quality of life burden associated with von Willebrand disease in adults and children : Systematic and targeted literature reviews
(
- Contribution to journal › Scientific review